22765-51-1Relevant articles and documents
Aromatic quinolinecarboxamides as selective, orally active antibody production inhibitors for prevention of acute xenograft rejection
Papageorgiou,Von Matt,Joergensen,Andersen,Wagner,Beerli,Than,Borer,Florineth,Rihs,Schreier,Weckbecker,Heusser
, p. 1986 - 1992 (2007/10/03)
The prevention of xenograft rejection is substantially dependent on inhibiting antibodies (Ab) produced by B-cells independently of T-cell signals (TI-1). Due to their ubiquitous biochemical mechanisms of action, the immunosuppressants currently employed